StockVS

Churchill Capital Corp X (CCCX) 股票分析

金融服务

Churchill Capital Corp X

$13.66

+$0.45 (+3.37%)

最后更新: 2026年2月13日

价格走势

分析

公司概述

Churchill Capital Corp X operates primarily within the financial services sector, specifically categorized under the industry of shell companies, focusing on executing business combination transactions such as mergers, amalgamations, asset acquisitions, and share exchanges. As a shell company, its operational scope is defined by the strategic intent to effect a merger or reorganization with one or more target entities rather than maintaining standard commercial operations. The company's market capitalization stands at $711.00M, while its annual revenue and employee count are not disclosed in the available financial data, reflecting the typical structure of special purpose acquisition vehicles before a definitive target is secured. These valuation figures indicate that the market assigns a significant asset value to the entity's potential for future business combination, even in the absence of traditional revenue streams or a formal workforce, positioning it as a key player in the corporate restructuring landscape as of February 13, 2026.

财务健康

The company reports a net income of $-31,429,724 for the trailing twelve months, while both revenue and EBITDA figures are unavailable, suggesting a pre-operational status where costs such as transaction expenses have incurred without corresponding revenue generation. The absence of reported free cash flow indicates that the company's financial flexibility is currently dictated by its cash reserves rather than operational cash generation, relying entirely on its existing liquidity to fund search costs and transaction fees. All three margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, which signifies that no revenue has been recognized to generate a margin, a characteristic inherent to shell companies awaiting a merger. In terms of solvency, the company holds $1.14M in cash against $0 in debt, resulting in a debt-to-equity ratio that is not calculable due to the lack of equity data, yet the zero debt load suggests a conservative balance sheet free from leverage obligations. However, the current ratio is listed at 0.04, which indicates a liquidity position where current assets are significantly lower than current liabilities, presenting a constraint on short-term obligations management prior to a successful merger. Return on equity and return on assets are both marked as unavailable, meaning these metrics cannot currently reflect management effectiveness as the company has not yet achieved profitable operations to measure against its equity or total assets.

估值评估

Trailing and forward P/E ratios are both unavailable, which prevents a direct comparison of current earnings multiples against future expectations, yet the absence of these metrics implies that valuation is not based on earnings but rather on asset value or potential merger premiums. The price-to-book ratio is recorded at -18.71, a negative figure that indicates the market values the company significantly below its book value, a common scenario for shell companies with minimal tangible assets or negative equity positions. Price-to-sales and EV/EBITDA multiples are also unavailable, suggesting that traditional valuation multiples are not applicable until the company transitions into a revenue-generating entity post-merger. Regarding trading range, the 52-week high is $27.50 and the 52-week low is $10.03, providing a context for the current price which sits within a volatile band driven by merger speculation. The beta value is unavailable, meaning there is no data to quantify the stock's price volatility relative to the broader market movements, though the wide spread between the 52-week high and low suggests high sensitivity to merger deal announcements.

Growth & Income

Revenue growth and earnings growth rates are both unavailable, indicating that the company is not currently generating the recurring revenue streams necessary to sustain year-over-year growth calculations or that such growth is contingent entirely on the completion of a future merger. For dividend payers, the dividend yield and payout ratio are both unavailable or zero, indicating that the company does not distribute earnings to shareholders. Specifically, the payout ratio is 0.0%, which confirms that the company reinvests all available resources, including its $1.14M cash reserve, into the search for a target business rather than paying dividends. Consequently, the overall growth and income profile is characterized by a lack of current income generation and a reliance on capital appreciation derived from the successful execution of a business combination transaction.

同行比较

Churchill Capital Corp X (CCCX) 在壳公司行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Churchill Capital Corp X CCCX $711.00M N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5
Bain Capital GSS Investment Corp. BCSS $595.68M N/A

壳公司行业平均市盈率为82.8倍。Churchill Capital Corp X的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Churchill Capital Corp X

As of February 13, 2026, Churchill Capital Corp X was acquired by ColdQuanta, Inc., in a reverse merger transaction. Churchill Capital Corp X focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2024 and is based in New York, New York.

公司简介以英文显示。

关键指标

市值
$711.00M
市盈率
N/A
52周最高
$27.50
52周最低
$10.03
平均成交量
2.12M

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States